| Website | bionanogenomics.com |
| Category | BioTech |
| Phone | 267-499-2014 |
| Employees | |
| Founded | 2003 |
| TOTAL | $23.3M |
| VENTURE FUNDING TOTAL | $23.3M |
| Series B, 3/11 Domain Associates Battelle Ventures Innovation Valley Partners KT Venture Group | $23.3M |
BioNanomatrix, Inc. develops nanoscale imaging and analytic platforms that are designed to analyze DNA and other genome-related peptides and proteins. The company’s technology provides analysis of genomic, epigenomic, and proteomic information with sensitivity at the single molecule level. Its products are used in genetic diagnostics, personalized medicine, and biomedical research applications. The company was founded in 2003 and is based in Philadelphia, Pennsylvania.
